These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1557 related articles for article (PubMed ID: 23034650)

  • 1. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
    Grivennikov SI; Wang K; Mucida D; Stewart CA; Schnabl B; Jauch D; Taniguchi K; Yu GY; Osterreicher CH; Hung KE; Datz C; Feng Y; Fearon ER; Oukka M; Tessarollo L; Coppola V; Yarovinsky F; Cheroutre H; Eckmann L; Trinchieri G; Karin M
    Nature; 2012 Nov; 491(7423):254-8. PubMed ID: 23034650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-23 to IL-17 cascade inflammation-related cancers.
    Wang K; Karin M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S87-90. PubMed ID: 26457610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
    Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.
    Lévy J; Cacheux W; Bara MA; L'Hermitte A; Lepage P; Fraudeau M; Trentesaux C; Lemarchand J; Durand A; Crain AM; Marchiol C; Renault G; Dumont F; Letourneur F; Delacre M; Schmitt A; Terris B; Perret C; Chamaillard M; Couty JP; Romagnolo B
    Nat Cell Biol; 2015 Aug; 17(8):1062-73. PubMed ID: 26214133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.
    Zeineldin M; Miller MA; Sullivan R; Neufeld KL
    Carcinogenesis; 2014 Aug; 35(8):1881-90. PubMed ID: 24894865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKIα ablation highlights a critical role for p53 in invasiveness control.
    Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
    Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus bovis Contributes to the Development of Colorectal Cancer via Recruiting CD11b⁺TLR-4⁺ Cells.
    Deng Q; Wang C; Yu K; Wang Y; Yang Q; Zhang J; Xu X
    Med Sci Monit; 2020 Aug; 26():e921886. PubMed ID: 32737964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
    Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
    Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATG16L1 in myeloid cells limits colorectal tumor growth in
    Salesse L; Duval A; Sauvanet P; Da Silva A; Barnich N; Godfraind C; Dalmasso G; Nguyen HTT
    Autophagy; 2024 Oct; 20(10):2186-2204. PubMed ID: 38818900
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A.
    Cui G; Li Z; Florholmen J; Goll R
    Biomed Pharmacother; 2021 Aug; 140():111761. PubMed ID: 34044278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases.
    Wang K; Grivennikov SI; Karin M
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii100-3. PubMed ID: 23253923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
    Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesis.
    Grasso F; Di Meo S; De Luca G; Pasquini L; Rossi S; Boirivant M; Biffoni M; Bignami M; Di Carlo E
    Oncotarget; 2015 Aug; 6(23):19671-84. PubMed ID: 26109431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells.
    Chung L; Thiele Orberg E; Geis AL; Chan JL; Fu K; DeStefano Shields CE; Dejea CM; Fathi P; Chen J; Finard BB; Tam AJ; McAllister F; Fan H; Wu X; Ganguly S; Lebid A; Metz P; Van Meerbeke SW; Huso DL; Wick EC; Pardoll DM; Wan F; Wu S; Sears CL; Housseau F
    Cell Host Microbe; 2018 Feb; 23(2):203-214.e5. PubMed ID: 29398651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
    Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
    Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
    Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.